After Gene Therapy: Hannah’s Journey Continues – PLoS Blogs (blog)
|
After Gene Therapy: Hannah’s Journey Continues
PLoS Blogs (blog) She’d put on 15 pounds since her gene therapy for giant axonal neuropathy (GAN) 9 months ago. Hannah wheeled around the teen-packed ballroom, a few kinky tendrils of her curls escaping an elegant upsweep and draping her smile, chatting with guests. |
|
Global Hemophilia Market Industry Analysis & Outlook 2017-2021: Gene Therapy to Transform Hemophilia Market …
Yahoo Finance Major trends of the market include development of novel hemophilia treatment, subcutaneous dosing and growing popularity of gene therapy. Further, growth prospects are hindered by high cost of therapy and consumers’ reluctance in switching to new … |
OncLive |
Dr. Wilky on Immunotherapy Trial in Sarcoma
OncLive Immunotherapy has dramatic responses for patients with sarcoma but it doesn’t work for everyone, states Wilky. One of the reasons oncologists believe immunotherapy may not be as successful is the potential problem of getting the immune cells into the … |
OncLive |
Dr. Wilky on Immunotherapy Trial in Sarcoma
OncLive Immunotherapy has dramatic responses for patients with sarcoma but it doesn’t work for everyone, states Wilky. One of the reasons oncologists believe immunotherapy may not be as successful is the potential problem of getting the immune cells into the … |
|
New Test Uses CRISPR to Detect Disease
Mental Floss CRISPR: It’s not just for making weird animals anymore. Scientists have used the genetic technology called CRISPR-Cas9 to create a super-sensitive, fast, and cheap diagnostic process for a range of diseases. They published their results in the journal … |
MIT News |
Scientists unveil CRISPR-based diagnostic platform
MIT News Unlike DNA-targeting CRISPR enzymes (such as Cas9 and Cpf1), Cas13a can remain active after cutting its intended RNA target and may continue to cut other nontargeted RNAs in a burst of activity that Zhang lab scientists referred to as “collateral cleavage. |